Cargando…
Treatment preferences in juvenile idiopathic arthritis – a comparative analysis in two health care systems
Autores principales: | Hugle, Boris, Benseler, Susanne M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194489/ http://dx.doi.org/10.1186/1546-0096-9-S1-P138 |
Ejemplares similares
-
Treatment preferences in juvenile idiopathic arthritis – a comparative analysis in two health care systems
por: Hugle, Boris, et al.
Publicado: (2013) -
PReS-FINAL-2031: Hyaluronic acid is a marker of active arthritis, but not systemic inflammation in systemic juvenile idiopathic arthritis
por: Hugle, B, et al.
Publicado: (2013) -
PReS-FINAL-2030: Treatment with leflunomide results in a higher flare rate of chronic uveitis compared to methotrexate in patients with juvenile idiopathic arthritis treated with both drugs
por: Bichler, J, et al.
Publicado: (2013) -
Systemic juvenile idiopathic arthritis in the republic of Bashkortostan
por: Malievskiy, VA
Publicado: (2011) -
Phenotypes of juvenile idiopathic arthritis
por: Rokhlina, Faina, et al.
Publicado: (2014)